SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRETTI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.313
EU - Europa 5.257
AS - Asia 4.189
SA - Sud America 606
AF - Africa 59
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 25.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.261
IT - Italia 1.978
SG - Singapore 1.750
CN - Cina 1.427
UA - Ucraina 922
DE - Germania 795
TR - Turchia 661
BR - Brasile 550
GB - Regno Unito 357
SE - Svezia 278
PL - Polonia 242
FI - Finlandia 211
ID - Indonesia 118
FR - Francia 104
RU - Federazione Russa 69
NL - Olanda 66
AT - Austria 47
HK - Hong Kong 43
BE - Belgio 37
CA - Canada 35
ES - Italia 29
IN - India 28
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
AR - Argentina 17
VN - Vietnam 15
BD - Bangladesh 14
CH - Svizzera 13
EC - Ecuador 13
IQ - Iraq 12
LT - Lituania 12
UZ - Uzbekistan 12
IR - Iran 11
MX - Messico 11
PK - Pakistan 11
AU - Australia 10
RO - Romania 10
AL - Albania 9
EU - Europa 9
IE - Irlanda 9
JP - Giappone 9
MA - Marocco 9
RS - Serbia 9
TN - Tunisia 9
KR - Corea 8
NP - Nepal 8
JO - Giordania 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CO - Colombia 6
KZ - Kazakistan 6
SM - San Marino 6
CL - Cile 5
DK - Danimarca 5
PT - Portogallo 5
TH - Thailandia 5
TW - Taiwan 5
EE - Estonia 4
KE - Kenya 4
PY - Paraguay 4
SA - Arabia Saudita 4
SN - Senegal 4
VE - Venezuela 4
BO - Bolivia 3
DZ - Algeria 3
HU - Ungheria 3
IL - Israele 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
OM - Oman 3
PE - Perù 3
SI - Slovenia 3
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
IS - Islanda 2
LY - Libia 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
ME - Montenegro 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
Totale 25.442
Salva come PNG Salva come JPEG
Città #
Fairfield 2.120
Woodbridge 1.929
Jacksonville 1.118
Houston 1.063
Ashburn 952
Chandler 951
Seattle 841
Wilmington 724
Cambridge 718
Santa Clara 700
Ann Arbor 697
Singapore 658
Izmir 462
Nanjing 366
Princeton 284
Dearborn 237
Warsaw 237
Beijing 210
Ferrara 207
Milan 173
San Diego 170
Bremen 162
Boardman 132
Rome 112
Jakarta 111
Nanchang 105
Hebei 83
Falls Church 75
New York 73
Shenyang 71
Shanghai 67
Tianjin 67
Bologna 66
Los Angeles 64
Nuremberg 57
Changsha 52
Jiaxing 51
Redwood City 48
Mountain View 47
Kunming 45
London 43
Naples 40
Orange 40
Hong Kong 39
São Paulo 38
Jinan 37
Norwalk 37
Brussels 34
Hefei 30
Helsinki 27
Zhengzhou 27
Florence 25
Guangzhou 25
Vienna 23
Munich 22
Ningbo 22
San Mateo 22
Turin 21
Palermo 20
Chicago 19
Verona 19
Lappeenranta 18
Council Bluffs 17
Rio de Janeiro 17
Parma 16
Toronto 16
Padova 15
Auburn Hills 14
Belo Horizonte 14
Indiana 14
Redmond 14
Reggio Nell'emilia 14
St Petersburg 14
Curitiba 13
Falkenstein 13
Modena 13
Taizhou 13
Des Moines 12
Brasília 11
Frankfurt am Main 11
Lanzhou 11
Ottawa 11
Tashkent 11
Torino 11
Brno 10
Catania 10
Changchun 10
Dallas 9
Dong Ket 9
The Dalles 9
Amsterdam 8
Baghdad 8
Bari 8
Benevento 8
Foligno 8
Imola 8
Lucca 8
Paris 8
Tappahannock 8
Terni 8
Totale 17.365
Salva come PNG Salva come JPEG
Nome #
Tumori Odontogeni misti: indagine sul significato delle correlazioni tra fibroma ameloblastico, fibro-odontoma ameloblastico e odontomi. 495
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 428
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 305
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 248
Survival of cancer patients in Europe: the EUROCARE study 238
I tumori in Italia, rapporto 2007: sopravvivenza. 228
I tumori in Emilia-Romagna 221
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 168
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 160
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening [Caratteristiche dei tumori del colon retto diagnosticati in Italia nei primi anni Duemila. Dati dello studio IMPATTO sdelo screening colorettale] 154
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 153
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 148
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 144
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 142
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 142
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 139
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 138
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 138
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 138
Completeness and timeliness: Cancer registries could/should improve their performance 137
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 136
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 134
Epidemiology of rare cancers and inequalities in oncologic outcomes 134
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 133
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 133
Survival from salivary glands adenoid cystic carcinoma in European populations 132
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 131
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 129
International incidence of childhood cancer, 2001-10: a population-based registry study 129
Impatto delle cure palliative sull'assistenza dei pazienti oncologici in fase terminale in provincia di Ferrara nel 2002. 128
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 128
Application of quantitative analysis to biologic profile evaluation in breast cancer 128
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 128
Treatment challenges in and outside a network setting: Soft tissue sarcomas 126
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 125
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 122
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 121
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. 121
Registro Tumori della provincia di Ferrara 120
The burden of HPV-related diseases in Italy, 2001-12 120
Cancer prevalence estimates in Europe at the beginning of 2000 119
Estimates of cancer burden in Emilia-Romagna 119
Early (short-interval) rescreen in mammography screening 118
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 118
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 117
I programmi di screening oncologici in Emilia-Romagna. I dati dei seminari regionali 2016 117
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 116
Regional inequalities in cancer care persist in Italy and can influence survival. 116
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 116
Cancer incidence and mortality trends from 2003 to 2014 in Italy 116
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 115
Survival of European patients with central nervous system tumors 115
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 115
Breast screening: axillary lymph node status of interval cancers by interval year 114
Incidence, survival and prevalence of myeloid malignancies in Europe 114
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 114
An estimate of the number of people in Italy living after a childhood cancer 114
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 113
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 113
Changes in cervical cancer incidence following the introduction of organized screening in Italy 113
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 113
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 113
Rare cancers are not so rare: the rare cancer burden in Europe 112
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 112
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 112
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 110
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 110
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 110
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 110
Estimates of cancer burden in Italy 109
Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study 109
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 109
Estimated and observed cancer incidence in Italy: a validation study. 108
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 108
Comparative cancer survival information in Europe 108
Rare cancers of the head and neck area in Europe 107
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 107
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 107
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 107
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 106
Italy, Ferrara province 106
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 106
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 106
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 106
National estimates of cancer patients survival in italy: A model-based method 105
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis 105
Cancer incidence and mortality in the province of Ferrara 1989-1990 105
Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: An analysis of geographic variability 105
null 104
The cure of cancer: A European perspective 104
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 104
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study 103
Incidence and survival of rare urogenital cancers in Europe 103
Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study 101
The burden of rare cancers in Europe 101
Epidemiology of glial and non-glial brain tumours in Europe 101
Rare thoracic cancers, including peritoneum mesothelioma 100
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project 100
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary 100
Treatment challenges in and outside a network setting: Head and neck cancers 99
Totale 13.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.541
Totale 135.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020592 0 0 0 0 0 0 0 0 0 340 148 104
2020/20213.526 232 268 274 407 265 314 155 416 179 410 367 239
2021/20222.556 87 296 205 167 129 144 136 195 109 204 188 696
2022/20232.594 313 127 52 267 490 382 61 256 332 34 170 110
2023/20241.428 171 169 60 75 99 125 62 74 44 67 90 392
2024/20254.633 209 148 529 192 733 429 372 402 895 724 0 0
Totale 25.966